[
  {
    "ts": null,
    "headline": "Boston Scientific: Premium MedTech Growth Story With Attractive Valuation Upside",
    "summary": "Boston Scientific is a Buy with a $109 target and 14% upside from strong demand, Q3 beats, raised FY25 guidance, and growth leadership. See why BSX stock is a buy.",
    "url": "https://finnhub.io/api/news?id=126501e3a4c6bd7045cd5e5f79cc5daf5c7783b329b513e7d8576d32dcbbf651",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766889617,
      "headline": "Boston Scientific: Premium MedTech Growth Story With Attractive Valuation Upside",
      "id": 137920501,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1440523601/image_1440523601.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Boston Scientific is a Buy with a $109 target and 14% upside from strong demand, Q3 beats, raised FY25 guidance, and growth leadership. See why BSX stock is a buy.",
      "url": "https://finnhub.io/api/news?id=126501e3a4c6bd7045cd5e5f79cc5daf5c7783b329b513e7d8576d32dcbbf651"
    }
  }
]